Laura Clague

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Escondido, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Laura Clague

Form 4 holding Director

Genasys Inc.

Security class
Common Stock
Shares / value
284,311
Estimated value
$525,975
Report date
27 Apr 2022
Price
$1.85
Ownership
Direct
Form 4 holding Chief Financial Officer

Travere Therapeutics, Inc.

Security class
Common Stock
Shares / value
35,655
Estimated value
$319,469
Report date
11 May 2022
Price
$8.96
Ownership
Direct
Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class
Common Stock
Shares / value
104,791
Estimated value
$266,169
Report date
14 Jun 2023
Price
$2.54
Ownership
Direct
Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class
Stock Option (Right to Buy)
Shares / value
35,380
Estimated value
$132,321
Report date
14 Jun 2023
Price
$3.74
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Genasys Inc.

Security class
Common Stock
Shares / value
2,000
Estimated value
$3,700
Report date
27 Apr 2022
Price
$1.85
Ownership
spouse
Form 4 holding Director

Genasys Inc.

Security class
Stock Option
Shares / value
0
Estimated value
Report date
27 Apr 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Laura Clague

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .